Skip to main content

Bracebridge Capital, LLC

Position in RNA — Atrium Therapeutics, Inc.

CIK 1426486 BOSTON, MA

Position in RNA

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$1,872,764
+$11,139 QoQ
Shares Held
139,239
0.0% QoQ
Ownership
0.814%
of shares outstanding
% of Portfolio
0.41%
of 13F equity value
Holder Rank
#22
of 154 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in RNA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Bracebridge Capital, LLC holds $1,872,764 across 2 Biotechnology names. RNA ranks #1 (100.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RNA
Atrium Therapeutics, Inc.
This page
139,239 $1,872,764

All Filings in RNA

Export CSV
2 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,872,764 139,239
2026-03-31 $1,861,625 139,239